Radiotherapy plays an important role in the management of a variety of malignancies. However, radiation pneumonitis, an acute or subacute lung injury occuring 6-24 weeks following radiotherapy, is the dominant dose-limiting normal tissue effect of thoracic radiotherapy and prediction of patients at risk, prevention and effective therapy is an important goal in improving outcomes of affected patients. Although the exact molecular etiology is controversial a potentially important cellular target in radiation-induced lung injury (RILI) Is the lung endothelium, a functionally dynamic tissue that forms a semi-permeable barrier that regulates influx of macromolecules and fluid between the vascular compartment and the lung interstitium. Disruption of endothelial cell (EC) barrier integrity is a cardinal feature of pulmonary inflammation in general and radiation pneumonitis in particular, resulting in increased permeability and alveolar flooding followed by physiological derangements including impaired gas exchange. We hypothesize that stabilization or enhanced restoration of lung EC barrier integrity is a critical step in preventing or reducing acute RILI. As we have previously demonstrated the potent endothelial barrier-protective effects of sphingosine 1-phosphjate (S1P), a bioactive phospholipid, both in vitro and in animal models of inflammatory lung injury we now hypothesize that sphingolipids may serve as a highly novel and effective therapy for RILI. The mechanisms of SIP-mediated EC barrier function involve ligation of specific SIP receptor subtypes (SI P I , S1P2, and S1P3) but the relevance of these effects clinically are unkown. We will examine the role of S1P receptor ligation in modulating RILI in a relevant murine model. We will then extend these findings to investigate novel RILI therapies, including SIP analogues and simvastatin, an HMG CoA-reductase inhibitor which we have confirmed is both directly EC barrier-protective and induces the marked upregulation of SI PI. Finally, mouse and human RILI samples will be used to identify novel SIP-related biomarkers and genomic markers. Collectively, these studies will confirm the therapeutic role of sphingolipids in RILI and will potentially lead to novel applications of our understanding of sphingolipid biology in the management of patients with RILI.

Public Health Relevance

Radiation pneumonitis is a potentially devasting,complication of thoracic radiotherapy for which effective therapies are non-existent. We propose to investigate strategies aimed at attenuating lung vascular permeability with respect to their therapeutic potential in radiation pneumonitis. These studies will focus on sphingolipids in this regard and will leverage the other studies proposed in this PPG for this purpose.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL098050-03
Application #
8502320
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
3
Fiscal Year
2013
Total Cost
$374,134
Indirect Cost
$114,264
Name
University of Illinois at Chicago
Department
Type
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Ackerman, Steven J; Park, Gye Young; Christman, John W et al. (2016) Polyunsaturated lysophosphatidic acid as a potential asthma biomarker. Biomark Med 10:123-35
Camp, Sara M; Chiang, Eddie T; Sun, Chaode et al. (2016) "Pulmonary Endothelial Cell Barrier Enhancement by Novel FTY720 Analogs: Methoxy-FTY720, Fluoro-FTY720, and β-Glucuronide-FTY720". Chem Phys Lipids 194:85-93
Ebenezer, David L; Fu, Panfeng; Natarajan, Viswanathan (2016) Targeting sphingosine-1-phosphate signaling in lung diseases. Pharmacol Ther 168:143-157
Viswanathan, P; Ephstein, Y; Garcia, J G N et al. (2016) Differential elastic responses to barrier-altering agonists in two types of human lung endothelium. Biochem Biophys Res Commun 478:599-605
Black, Katharine E; Berdyshev, Evgeny; Bain, Gretchen et al. (2016) Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis. FASEB J 30:2435-50
Ebenezer, David L; Fu, Panfeng; Suryadevara, Vidyani et al. (2016) Epigenetic regulation of pro-inflammatory cytokine secretion by sphingosine 1-phosphate (S1P) in acute lung injury: Role of S1P lyase. Adv Biol Regul :
Jiang, Ying; Sverdlov, Maria S; Toth, Peter T et al. (2016) Phosphatidic Acid Produced by RalA-activated PLD2 Stimulates Caveolae-mediated Endocytosis and Trafficking in Endothelial Cells. J Biol Chem 291:20729-38
Zhang, Chongben; Hwarng, Gwen; Cooper, Daniel E et al. (2015) Inhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol. J Biol Chem 290:3519-28
Huang, Long Shuang; Berdyshev, Evgeny V; Tran, John T et al. (2015) Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy. Thorax 70:1138-48
Letsiou, Eleftheria; Sammani, Saad; Zhang, Wei et al. (2015) Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding. Am J Respir Cell Mol Biol 52:193-204

Showing the most recent 10 out of 48 publications